Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

65.41 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
DEXCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating DexCom, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DEXCOM INC (NASDAQ:DXCM): A Top Affordable Growth Pick with Strong Fundamentals and Fair Valuation
DexCom (DXCM) offers strong growth, fair valuation, and solid profitability, making it a top pick for investors seeking affordable growth in the medical device sector. 
Via Chartmill
Uncover the latest developments among S&P500 stocks in today's session.
Get insights into the S&P500 index performance on Monday. Explore the top gainers and losers within the S&P500 index in today's session. 
Via Chartmill
Meta, Microsoft Power Wall Street To New Records Despite Inflation Jump: What's Moving Markets Thursday?
A post-earnings surge in Meta Platforms Inc. (NASDAQ:META) and Microsoft Corp. 
Via Benzinga
Topics Economy
Earnings Scheduled For July 30, 2025
 
Via Benzinga
What Does the Market Think About DexCom?
 
Via Benzinga
Stay informed with the top movers within the S&P500 index on Monday.
Curious about the S&P500 stocks that are in motion on Monday? Join us as we explore the top movers within the S&P500 index during today's session. 
Via Chartmill
Gapping S&P500 stocks in Monday's session
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Monday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
DexCom (DXCM) Q2 Revenue Jumps 15%
Via The Motley Fool
Topics Economy
Forecasting The Future: 11 Analyst Projections For DexCom
 
Via Benzinga
Explore the top gainers and losers within the S&P500 index in today's session.
Stay informed about the performance of the S&P500 index in the middle of the day on Thursday. Uncover the top gainers and losers in today's session for valuable insights. 
Via Chartmill
Gapping S&P500 stocks in Thursday's session
Looking for opportunities in today's market? Check out the S&P500 gap up and gap down stocks on Thursday and stay ahead of the market trends. 
Via Chartmill
DexCom’s (NASDAQ:DXCM) Q2 Sales Beat Estimates
Medical device company DexCom (NASDAQ:DXCM) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.2% year on year to $1.16 billion. The company expects the full year’s revenue to be... 
Via StockStory
Topics Earnings
Stay updated with the S&P500 stocks that are on the move in today's after-hours session.
After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable S&P500 performers among the top gainers and losers. 
Via Chartmill
Dexcom Earnings Beat. Diabetes Device Maker Names New CEO.
Dexcom stock fell late Wednesday after it reported Q2 earnings that topped expectations and named a new chief executive officer. 
Via Investor's Business Daily
Topics Artificial Intelligence Earnings Initial Public Offering
Dexcom Reports Second Quarter 2025 Financial Results, Updates Full Year 2025 Guidance and Announces CEO Succession Plan
From DexCom, Inc.
Via Business Wire
Earnings To Watch: DexCom (DXCM) Reports Q2 Results Tomorrow
Medical device company DexCom (NASDAQ:DXCM) will be reporting results this Wednesday after market hours. Here’s what to look for. 
Via StockStory
Topics Artificial Intelligence
Dexcom Launches Revolutionary AI-Powered Meal Logging Feature Across Glucose Biosensing Portfolio
From DexCom, Inc.
Via Business Wire
1 Volatile Stock Worth Your Attention and 2 We Find Risky
A highly volatile stock can deliver big gains - or just as easily wipe out a portfolio if things go south. While some investors embrace risk, mistakes can be costly for those who aren’t prepared. 
Via StockStory
DEXCOM INC (NASDAQ:DXCM): A Strong Growth Stock with Positive Technical Breakout Signals
DexCom (DXCM) is a top growth stock with strong fundamentals, solid profitability, and bullish technical breakout signals, making it a compelling investment opportunity. 
Via Chartmill
Why This Beaten-Down Medical Device Stock Could Be Your Best Investment for the Next 5 Years
Via The Motley Fool
Topics Government
Dexcom Unveils Season 4 Roster for Game-Changing NIL Program at Signing Day Camp Hosted by Mark Andrews
From DexCom, Inc.
Via Business Wire
Beyond The Numbers: 8 Analysts Discuss DexCom Stock
 
Via Benzinga
How To Trade This 150% Gainer Chasing A Cure For Type 1 Diabetes
An update on Sana Biotechnology. 
Via Benzinga
DEXCOM INC (NASDAQ:DXCM) - A Strong Technical Setup in the Medical Device Sector
DEXCOM INC (NASDAQ:DXCM) shows a strong technical setup with positive trends, consolidation, and institutional interest, making it a breakout candidate for traders. 
Via Chartmill
Artificial Intelligence Revolutionizing Early Detection of Diabetic Retinopathy Creating a Multi-Billion Dollar Revenue Opportunity
EQNX::TICKER_START (OTCQB:AVAI),(NYSE:ABT),(NASDAQ:DXCM),(NASDAQ:IRTC),(NASDAQ:TNDM) EQNX::TICKER_END 
Via FinancialNewsMedia
Topics Artificial Intelligence
2 Stocks to Buy on the Dip and Hold for 10 Years
Via The Motley Fool
3 Cash-Heavy Stocks Worth Your Attention
In a world where many businesses have shaky balance sheets, some have ignored the crowd and exercised prudence. These cash-heavy companies shine bright for their financial discipline, resilience, and... 
Via StockStory
DEXCOM INC (NASDAQ:DXCM) – A Strong Growth Stock with Technical Breakout Potential
DEXCOM INC (NASDAQ:DXCM) shows strong growth fundamentals and a promising technical setup, making it a stock to watch for breakout potential in the medical device sector. 
Via Chartmill
Why Diabetes Titans Dexcom, Tandem, Insulet Just Hit The Skids
A proposal would cut Medicare reimbursements for some medical devices using a competitive bidding process. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
38 39 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.